Abstract
Background Diabetic Macular Edema (DME) is a complication of diabetes which, when untreated, leads to vision loss. Screening for signs of diabetic eye disease, including DME, is recommended for all patients with diabetes at least every one to two years, however, compliance with this standard is low.
Methods A deep learning model was trained for DME detection using the EyePACS dataset. Data was randomly assigned, by participant, into development (n= 14,246) and validation (n= 1,583) sets. Analysis was conducted on the single image, eye, and patient levels. Model performance was evaluated using sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Independent validation was further performed on the IDRiD dataset, as well as new data.
Findings At the image level, sensitivity of 0.889 (CI 95% 0.878, 0.900), specificity of 0.889 (CI 95% 0.877, 0.900), and AUC of 0.954 (CI 95% 0.949, 0.959) were achieved. At the eye level, sensitivity of 0.905 (CI 95% 0.890, 0.920), specificity of 0.902 (CI 95% 0.890, 0.913), and AUC of 0.964 (CI 95% 0.958, 0.969) were achieved. At the patient level, sensitivity of 0.901 (CI 95% 0.879, 0.917), specificity of 0.900 (CI 95% 0.883, 0.911), and AUC of 0.962 (CI 95% 0.955, 0.968) were achieved.
Interpretation DME can be detected from color fundus imaging with high performance on all analysis metrics. Automatic DME detection may simplify screening, leading to more encompassing screening for diabetic patients. Further prospective studies are necessary.
Funding Funding was provided by AEYE Health Inc.
Competing Interest Statement
IB and RA are employees of AEYE Health. DM and ZDA are COO and CEO of AEYE Health.
Funding Statement
Funding provided by AEYE Health Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Sterling Institutional Review Board reviewed the study and an exemption was obtained. The Lahey Hospital institutional (Burlington, MA, USA) review board reviewed this study and an exemption was obtained.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos